Drug Profile
Research programme: TRIM proteins - Myrexis
Alternative Names: TRIM proteins; TRIM37 protein; Tripartite motif proteinsLatest Information Update: 26 Nov 2012
Price :
$50
*
At a glance
- Originator Myriad Pharmaceuticals
- Developer Myrexis; University of Minnesota
- Class Proteins
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections